Upper Extremity Aerobic Exercise Training Program: 12 weeks of supervised upper limb aerobic exercise training, 3 sessions per week, 25 minutes per session.
Study summary
The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.
Eligibility
Sex
FEMALE
Min age
40 Years
Max age
69 Years
Healthy volunteers
No
Inclusion Criteria:
* To be between the ages of 40-69,
* Baseline left ventricular ejection fraction (LVEF) \>50%,
* Absence of coronary artery disease and haemodynamically significant valvular heart disease,
* Absence of carotid atherosclerotic plaques,
* Volunteering to participate in the research,
* At least 15 months after breast cancer surgery,
* No problems in reading and/or understanding the scales and being able to co-operate with the tests.
* Physically inactive (60 minutes of structured exercise per week \<).
Exclusion Criteria:
* Presence of active infection,
* Presence of bilateral breast cancer,
* History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
* Having a neurological disease or other clinical diagnosis that may affect cognitive status,
* Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy
* Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
* Presence of unstable hypertension or diabetes mellitus.
Primary outcome measure(s)
Arterial Stiffness — one years Arterial stiffness will be assessed noninvasively using the pulse wave velocity (PWV) technique with the Mobil-O-GRAPH (TG) (I.E.M., Stolberg, Germany), an oscillometer-based device. Pulse wave velocity, augmentation pressure, reflection magnitude, agumentation index parameters will be recorded.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.